Navigation Links
Polaris Group to Highlight Clinical Development Plans for Phase 3-Ready Candidate, ADI-PEG 20, During Symposium in Taiwan
Date:5/12/2011

/p>

Additionally, Li-Zong Chen, M.D., Ph.D., of the National Institute of Health, and Jien-Fong Lee, M.D., of Chimei Hospital in Taiwan, will present data about ASS1 deficiency in sarcoma and its potential use as an indicator for cancer prognosis and treatment.  John Bomalaski, M.D., executive vice president, medical affairs, of Polaris Group will present data demonstrating the effectiveness of ADI-PEG 20 as a treatment for leukemia, lymphoma and sarcoma.  

In addition, Hsing-Jien Kung, Ph.D., of UC Davis Cancer Center will present data about ADI-PEG 20, autophagy and apoptosis, and implications for prostate cancer treatment.

Individuals interested in attending the symposium should e-mail ivylin@tdwpharma.com to register for the event.

About ADI-PEG 20

ADI-PEG 20 is a biologic being developed by Polaris to treat cancers carrying a major metabolic defect that renders them, unlike normal cells, unable to make arginine internally. Because arginine is one of the 20 amino acids that are essential for protein synthesis and survival of cells, these cancer cells become dependent upon the external supply of arginine to survive and grow. ADI-PEG 20 works by systemically depleting the external supply of arginine which causes these arginine-dependent cancer cells to die while leaving the normal cells unharmed.

Multiple cancers have been reported to have a high degree of arginine-dependency. Phase 2 clinical trials have yielded positive results in patients with hepatocellular carcinoma or metastatic melanoma, and Phase 2 trials for small cell lung cancer and mesothelioma are currently ongoing. Polaris also plans to initiate clinical studies in prostate cancer, pancreatic cancer, leukemia, lymphoma and sarcoma this year.

About Polaris Group

Polaris Group is a privately held multinational biopharmaceutical company that specializes in the research and development of
'/>"/>

SOURCE Polaris Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Groups Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
2. Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
3. Simcere Pharmaceutical Group Filed 2010 Annual Report on Form 20-F
4. NxStage® Supports Initiative by Patient Advocacy Groups to Educate Policymakers about the Benefits of Frequent Home Hemodialysis
5. Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
6. Winner Medical Group Inc. to Host Second Quarter 2011 Earning Conference Call on Wednesday, May 11, 2011 at 08:30 a.m. EDT
7. Chronic Disease Research Group Study Shows Daily Home Hemodialysis Therapy with the NxStage® System One™ is Associated with Lower Risk of Mortality and Higher Survival Estimates Compared to Conventional Thrice-Weekly Dialysis
8. Hanger Orthopedic Group Reports First Quarter Results
9. Global Pharm Holdings Group Obtains Business License for its Newly Established Joint-Venture in Jinan City
10. Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011
11. Important Information for Atwater Carey First Aid Kit Consumers Regarding Triad Groups Povidone Iodine Prep Pads
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Researchers from the North American Menopause Society (NAMS) found ... too high, 1 putting women at risk for ... close to menopause are commonly told to take supplements ... as osteoporosis, to which they are particularly prone. ... calcium they typically get through their food sources before ...
(Date:7/23/2014)... 2014 This September leading clinicians in orthodontics ... Vegas for DOCtalk 2014 —a "Dynamic ... thinker and private practitioner Dr. David Sarver , ... discuss clinical and practice management efficiency and high quality ... opportunity to welcome fresh thinking and join a community ...
(Date:7/23/2014)... 2014 Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... and research facility: Ampio Pharmaceuticals, 373 Inverness ... (720) 437-6500 Michael Macaluso , Ampio,s ... facility will be fully operational this summer, right ... Ampion TM necessary to accommodate the company,s BLA ...
Breaking Medicine Technology:Women Taking Too Much Calcium Create Health Risk 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2
... 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: ... a pharmaceutical company dedicated to improving healthcare through ... range of prescription and over-the-counter ("OTC") products, today ... Mr. Tony Liu and Chief Financial Officer, Ms. ...
... that a new market research report is available in ... in China http://www.reportlinker.com/p0363587/The-Top-10-CMOs-in-China.html ... and future outlook of CMO industry in China. It ... the top 10 CMOs. Other leading players are also ...
Cached Medicine Technology:American Oriental Bioengineering's CEO and CFO Visit the United States as Entrepreneur Representatives of President Hu Jintao's Delegation 2Reportlinker Adds The Top 10 CMOs in China 2
(Date:7/23/2014)... Roanoke, Virginia (PRWEB) July 23, 2014 ... Levelers headquarters in Roanoke, Virginia on Friday, July 18. ... Virginia Amateur Sports Subway Commonwealth Games, an Olympic-style event ... in its first year as a premier sponsor of ... lifestyles to people of all ages and all activity ...
(Date:7/23/2014)... Amy Norton HealthDay Reporter ... a girl,s first menstrual period may be determined by hundreds, ... Researchers have identified over 100 regions of DNA ... woman,s first menstrual period. The researchers hope these findings will ... ranging from type 2 diabetes to breast cancer. "These ...
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics ... Orthopaedic Certified Specialist (OCS) or Sports ... DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, ... Leech, PT, DPT, OCS, and Mary Grimberg, PT, DPT, ...
(Date:7/23/2014)... Hudson County, NJ (PRWEB) July 23, 2014 ... Hospital is the first hospital in New Jersey to ... and most advanced robotics platform in the da Vinci ... leap and a profound step forward in innovation. The ... be used across a wide spectrum of minimally invasive ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Recently, Agebc.com ... . Now, the company is announcing a promotion of ... the promotion will end at the end of this ... in many popular styles, like A-line, mermaid, ball-gown, empire, ... wedding dresses and other special-occasion dresses for women, and ...
Breaking Medicine News(10 mins):Health News:US Olympian Chad Hedrick Visits Foot Levelers 2Health News:Gene Study Gives New Insight Into Puberty in Girls 2Health News:Gene Study Gives New Insight Into Puberty in Girls 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... Deanne Thompson of the Orange County Health Care Agency has confirmed ... have contributed to the outbreak of a lung fluke parasite infection ... every one of these eight -- or any of them -- ... month only four people had been confirmed as being infected, but ...
... UNAIDS, the available funding for 2006 was $8.9 billion ... the national governments to find strategies to maximize the ... The conference will attempt to address the issue through ... conference, which will be held Wednesday, September 13 to ...
... their plans to go into a partnership with NASPGHAN ... ,International publisher John Wiley & Sons, Inc., had ... a new agreement with the North American Society for ... Association for the Study of Liver Diseases (AASLD). ...
... According to a recent study by psychologists at the University ... more acceptable to the learned than the// poorly educated. ... BA Festival of Science on Setpember 5. ,If ... the UK "design into" their kids, this was studied by ...
... People in New Zealand have found a unique ... pregnancy is a vice. Church bells rang in ... ,This ritual is followed worldwide on the ... against raise awareness of Fetal Alcohol Syndrome. Organizer ...
... below the age of five will be administered anti-polio ... reported //no polio case for the second consecutive year. ... Delhi Chief Minister Sheila Dikshit Saturday said the state ... spreading of the virus from neighbouring Uttar Pradesh. ...
Cached Medicine News:Health News:International Conference on The Costs And Benefits of HIV/AIDS Interventions in Developing Countries to be hosted by Harvard 2Health News:Designer babies 2Health News:1.8 mn Delhi Children to Receive Anti-polio Drops 2
... injectable low osmolar, nonionic, contrast media ... biologically inert when injected intra-arterially. Each ... of ioversol, 3.6 mg of tromethamine ... of edetate calcium disodium as a ...
... is a non-ionic monomeric contrast medium for ... and children. After a decade of clinical ... examinations, IMAGOPAQUE has proven to be a ... hundreds of radiology departments.Results from large multicentre ...
... ProHance® (gadoteridol) is a contrast medium ... form of a sterile, apyrogenic solution for ... contrast enhancement of the brain, spine and ... with unenhanced MRI) of lesions with abnormal ...
... Advanced Magnetics' contrast agent for use with MRI ... the first organ-specific MRI contrast agent to be ... agent is taken up by macrophages found only ... tumors. The liver is a principal site for ...
Medicine Products: